Leslie Jonas

2.7k total citations · 1 hit paper
11 papers, 2.2k citations indexed

About

Leslie Jonas is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Leslie Jonas has authored 11 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Microbiology. Recurrent topics in Leslie Jonas's work include Pneumonia and Respiratory Infections (6 papers), HIV/AIDS drug development and treatment (5 papers) and Bacterial Infections and Vaccines (5 papers). Leslie Jonas is often cited by papers focused on Pneumonia and Respiratory Infections (6 papers), HIV/AIDS drug development and treatment (5 papers) and Bacterial Infections and Vaccines (5 papers). Leslie Jonas collaborates with scholars based in United States, Japan and Qatar. Leslie Jonas's co-authors include Joseph J. Eron, Anne R. Meibohm, Emilio A. Emini, Roy M. Gulick, Diane V. Havlir, Douglas D. Richman, John W. Mellors, Deborah K. McMahon, Jon H. Condra and Charles J. Gonzalez and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Leslie Jonas

10 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

1997 1.5k citations Roy M. Gulick, John W. Mellors et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Leslie Jonas	1.7k	1.7k	486	234	189	11	2.2k
Jeffrey P. Nadler	1.1k 0.6×	1.0k 0.6×	632 1.3×	257 1.1×	240 1.3×	28	1.9k
J. M. A. Lange	1.2k 0.7×	1.3k 0.8×	343 0.7×	154 0.7×	184 1.0×	22	1.7k
J Aboulker	1.1k 0.6×	1.1k 0.6×	435 0.9×	338 1.4×	254 1.3×	91	1.8k
Alain Lafeuillade	1.1k 0.6×	1.2k 0.7×	368 0.8×	280 1.2×	259 1.4×	89	1.7k
Benoît Trottier	1.7k 1.0×	1.5k 0.9×	390 0.8×	374 1.6×	261 1.4×	68	2.2k
Lewis K. Schrager	1.5k 0.9×	1.2k 0.7×	889 1.8×	192 0.8×	705 3.7×	34	2.4k
Andrew D. Redd	1.1k 0.6×	850 0.5×	586 1.2×	130 0.6×	203 1.1×	104	1.6k
Manish Sagar	1.4k 0.8×	1.5k 0.9×	477 1.0×	113 0.5×	549 2.9×	69	2.3k
Timothy Wilkin	1.8k 1.0×	1.6k 1.0×	1.3k 2.7×	324 1.4×	223 1.2×	101	3.1k
Remko van Leeuwen	1.8k 1.0×	1.5k 0.9×	651 1.3×	252 1.1×	208 1.1×	40	2.4k

Countries citing papers authored by Leslie Jonas

Since Specialization

Citations

This map shows the geographic impact of Leslie Jonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Jonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Jonas more than expected).

Fields of papers citing papers by Leslie Jonas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Jonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Jonas. The network helps show where Leslie Jonas may publish in the future.

Co-authorship network of co-authors of Leslie Jonas

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Jonas. A scholar is included among the top collaborators of Leslie Jonas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Jonas. Leslie Jonas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Chodakewitz, Jeffrey, John W. Mellors, Anne R. Meibohm, et al.. (2020). Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. UNC Libraries.

Günthard, Huldrych F., Diane V. Havlir, Susan A. Fiscus, et al.. (2001). Residual Human Immunodeficiency Virus (HIV) Type 1 RNA and DNA in Lymph Nodes and HIV RNA in Genital Secretions and in Cerebrospinal Fluid after Suppression of Viremia for 2 Years. The Journal of Infectious Diseases. 183(9). 1318–1327. 122 indexed citations

Gulick, Roy M., John W. Mellors, Diane V. Havlir, et al.. (2000). 3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine. Annals of Internal Medicine. 133(1). 35–39. 154 indexed citations

Gulick, Roy M., John W. Mellors, Diane V. Havlir, et al.. (1998). Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 Infection. JAMA. 280(1). 35–35. 207 indexed citations

Gulick, Roy M., John W. Mellors, Diane V. Havlir, et al.. (1997). Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy. New England Journal of Medicine. 337(11). 734–739. 1531 indexed citations breakdown →

West, David J., et al.. (1997). Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. The Pediatric Infectious Disease Journal. 16(6). 593–599. 26 indexed citations

Mulholland, Kim, Vincent I. Ahonkhai, A.M. Greenwood, et al.. (1993). Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis Group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheriatetanus-pertussis vaccine in young Gambian infants. The Pediatric Infectious Disease Journal. 12(8). 632–637. 27 indexed citations

Calandra, Gary, L.J. Lukacs, Leslie Jonas, et al.. (1993). Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses. Vaccine. 11. S58–S62. 14 indexed citations

Ahonkhai, Vincent I., L.J. Lukacs, Leslie Jonas, & Gary Calandra. (1991). Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein. Vaccine. 9. S38–S41. 15 indexed citations

10.

Ahonkhai, Vincent I., L.J. Lukacs, Leslie Jonas, et al.. (1990). Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIBTM): Clinical Evaluation. PEDIATRICS. 85(4). 676–681. 31 indexed citations

11.

Ahonkhai, Vincent I., L.J. Lukacs, Leslie Jonas, et al.. (1990). Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.. PubMed. 85(4 Pt 2). 676–81. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact